ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

URN to cite this document:: urn:nbn:de:bvb:355-epub-452406
DOI to cite this document:: 10.5283/epub.45240

Dreier, Esther ; Malfertheiner, Maximilian Valentin

; Dienemann, Thomas ; Fisser, Christoph

; Foltan, Maik ; Geismann, Florian

; Graf, Bernhard ; Lunz, Dirk ; Maier, Lars Siegfried

; Müller, Thomas ; Offner, Robert ; Peterhoff, David

; Philipp, Alois ; Salzberger, Bernd

; Schmidt, Barbara ; Sinner, Barbara ; Lubnow, Matthias

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(586kB)

Date of publication of this fulltext: 18 Mar 2021 10:13

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains unclear. Our aim was to investigate the clinical course and outcome of those patients and to identify factors associated with the need for prolonged ECMO therapy. Methods: A retrospective single-center study on patients with ...